share_log

bluebird bio | 3: Initial statement of beneficial ownership of securities-Officer Sterling O. James

bluebird bio | 3: Initial statement of beneficial ownership of securities-Officer Sterling O. James

bluebird bio | 3:首次持股聲明-高管 Sterling O. James
美股sec公告 ·  06/13 17:04
Moomoo AI 已提取核心訊息
On June 10, 2024, Sterling O. James, the Chief Financial Officer of bluebird bio, Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as mandated by Section 16(a) of the Securities Exchange Act of 1934. The filing, which is a standard requirement for officers, directors, and certain beneficial owners of public companies, indicates that Sterling O. James does not beneficially own any securities in the company. The form was filed individually by James and was signed by Sydney Gaylin, Attorney-in-Fact, on June 13, 2024. This filing is part of the regulatory requirements that ensure transparency of ownership by key executives and is closely monitored by investors for any changes in ownership that might influence the company's stock performance.
On June 10, 2024, Sterling O. James, the Chief Financial Officer of bluebird bio, Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as mandated by Section 16(a) of the Securities Exchange Act of 1934. The filing, which is a standard requirement for officers, directors, and certain beneficial owners of public companies, indicates that Sterling O. James does not beneficially own any securities in the company. The form was filed individually by James and was signed by Sydney Gaylin, Attorney-in-Fact, on June 13, 2024. This filing is part of the regulatory requirements that ensure transparency of ownership by key executives and is closely monitored by investors for any changes in ownership that might influence the company's stock performance.
2024年6月10日,bluebird bio股份有限公司的首席財務官Sterling O. James根據1934年證券交易法第16(a)條規定向證券交易委員會提交了證券利益初步聲明。該申報是公共公司官員、董事和某些有益所有人的標準要求,表明Sterling O. James未對公司擁有任何證券利益。這份表格是由詹姆斯個人提交的,並於2024年6月13日由律師代理Sydney Gaylin簽署。這項申報是確保關鍵高管的所有權透明度的監管要求的一部分,受到投資者的密切關注,以了解任何可能影響公司股票表現的所有權變化。
2024年6月10日,bluebird bio股份有限公司的首席財務官Sterling O. James根據1934年證券交易法第16(a)條規定向證券交易委員會提交了證券利益初步聲明。該申報是公共公司官員、董事和某些有益所有人的標準要求,表明Sterling O. James未對公司擁有任何證券利益。這份表格是由詹姆斯個人提交的,並於2024年6月13日由律師代理Sydney Gaylin簽署。這項申報是確保關鍵高管的所有權透明度的監管要求的一部分,受到投資者的密切關注,以了解任何可能影響公司股票表現的所有權變化。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息